Harmful cholesterol levels cut in half with one-time gene editing drug in early trial
One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is uncertain.
New gene-editing therapy may lower cholesterol permanently, study finds
A new CRISPR-based gene-editing therapy shows promise for treating severe high cholesterol by disabling the ANGPTL3 gene.
Can a One-Time Gene Therapy Lower Cholesterol?
Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.
CRISPR gene therapy slashes 'bad' cholesterol, triglycerides by half in small study
A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half in four people taking the highest dose, raising ...
CRISPR updates early-stage trial data for heart disease therapy
CRISPR Therapeutics (CRSP) posts new data from an early stage trial for CTX310, an in vivo gene editing therapy for heart ...
Gene Therapy Reverses Diabetes Heart Failure
Scientists have reversed diabetic heart failure with a genetic therapy in mice and a miniature human hearts made from stem ...
Labroots
A Non-Viral Gene Therapy for Heart Disease
Heart diseases are still the number one cause of death worldwide. According to the World Health Organization, cardiovascular diseases led to the deaths of about 9.8 million people in 2022 alone, ...
Medera Announces First Patient Dosed in Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial Evaluating SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the first patient has ...
Scientists Use “Supercentenarian Longevity Gene” to Slow Rapid Aging Disease
Researchers discovered that a longevity gene from centenarians can reverse heart damage linked to progeria, suggesting a new approach to treating rapid and age-related heart aging. A major advancement ...